Abstract
BackgroundTypical liquid biopsy panels offer a limited understanding of tumor biology, potentially under-representing the heterogeneity of resistance in late-stage cancers. Here, diminished scope can result in undetected, therapeutically-relevant biomarkers which...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have